LeMaitre Vascular to Present at Upcoming Investor Conferences

LeMaitre Vascular (Nasdaq:LMAT) is set to participate in four key investor conferences in February and March 2021.

Rhea-AI Summary

LeMaitre Vascular (Nasdaq:LMAT) is set to participate in four key investor conferences in February and March 2021. David Roberts, President, will present at:

• SVB Leerink's Global Healthcare Conference on February 26, 2021, at 8:40 AM EST
• Barclays Global Healthcare Conference on March 9, 2021, at 1:50 PM EST
• 33rd Annual Roth Conference on March 15, 2021, on demand
• Oppenheimer's Healthcare Conference on March 16, 2021, at 3:10 PM EDT

LeMaitre Vascular specializes in devices and services for peripheral vascular disease, helping over 200 million people globally.

Argus Session date unavailable

-0.51% session move Open Argus

Details

News Market Reaction – LMAT

The recorded move for LMAT in the trading session of this news was -0.51%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in four upcoming investor conferences.

David Roberts, President, is scheduled to present at the following virtual conferences:

• SVB Leerink's 10th Annual Global Healthcare Conference on Friday, February 26, 2021, at 8:40 AM EST
• Barclays Global Healthcare Conference on Tuesday, March 9, 2021, at 1:50 PM EST
• 33^rd Annual Roth Conference on Monday, March 15, 2021, on demand
• Oppenheimer 31^st Annual Healthcare Conference on Tuesday, March 16, 2021, at 3:10 PM EDT

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What conferences is LeMaitre Vascular participating in February and March 2021?

LeMaitre Vascular will participate in four investor conferences: SVB Leerink on February 26, Barclays on March 9, Roth on March 15, and Oppenheimer on March 16, 2021.

Who is presenting for LeMaitre Vascular at the upcoming conferences?

David Roberts, the President of LeMaitre Vascular, is scheduled to present at the upcoming conferences.

When will David Roberts present at the SVB Leerink's Global Healthcare Conference?

David Roberts will present at SVB Leerink's Global Healthcare Conference on February 26, 2021, at 8:40 AM EST.

What is the focus of LeMaitre Vascular as a company?

LeMaitre Vascular focuses on developing devices and services for the treatment of peripheral vascular disease, serving the needs of vascular surgeons.

How many people are affected by peripheral vascular disease worldwide?

Peripheral vascular disease affects over 200 million people globally.